Conclusion: T. gondii IgG+ antibody was significantly associated with liver injury biomarkers (ALT, AST, GGT, and ALP) and an increased risk of CLD and NAFLD. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.